A reexamination of the costs of medical R&D regulation
Year of publication: |
2012
|
---|---|
Authors: | Philipson, Tomas J. ; Sun, Eric ; Goldman, Dana P. ; Jena, Anupam B. |
Published in: |
Forum for health economics & policy : an evolving collection of symposia on important health care issues. - Berlin : De Gruyter, ISSN 1558-9544, ZDB-ID 2233218-2. - Vol. 15.2012, 3, p. 132-159
|
Subject: | Pharmakologie | Pharmacology | Innovation | Technologiepolitik | Technology policy | Regulierung | Regulation | Soziale Kosten | Social costs | USA | United States |
Extent: | graph. Darst. |
---|---|
Type of publication: | Article |
Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
Language: | English |
Notes: | Systemvoraussetzungen: Acrobat Reader |
Other identifiers: | 10.1515/fhep-2012-0020 [DOI] |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Policy and regulatory challenges for plant-made pharmaceuticals in the United States
Stewart, Patrick A., (2009)
-
Eller, Brian Bernard, (2015)
-
Rzakhanov, Zaur, (2014)
- More ...
-
Drug licenses : a new model for pharmaceutical pricing
Goldman, Dana P., (2008)
-
A reexamination of the costs of medical R&D regulation
Philipson, Tomas J., (2012)
-
The contributions of improved therapy and earlier detection to cancer survival gains, 1988 - 2000
Sun, Eric, (2010)
- More ...